Affluent Medical S.A.
AFME.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €53 | €54 | €32 | €106 |
| - Cash | €1 | €2 | €3 | €11 |
| + Debt | €16 | €17 | €18 | €20 |
| Enterprise Value | €68 | €69 | €47 | €114 |
| Revenue | €4 | €1 | €1 | €1 |
| % Growth | 236.4% | -8.6% | -7.7% | – |
| Gross Profit | -€9 | -€1 | -€1 | -€1 |
| % Margin | -225.2% | -98% | -82.4% | -88.9% |
| EBITDA | -€13 | -€13 | -€13 | -€11 |
| % Margin | -326.4% | -1,090.1% | -986.9% | -750.4% |
| Net Income | -€15 | -€16 | -€15 | -€15 |
| % Margin | -357.9% | -1,278.8% | -1,137.2% | -1,021.4% |
| EPS Diluted | -0.37 | -0.54 | -0.81 | -0.8 |
| % Growth | 31.5% | 33.3% | -1.3% | – |
| Operating Cash Flow | -€11 | -€12 | -€11 | -€12 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€11 | -€12 | -€11 | -€13 |